Company attributes
Location
AngelList URL
CIK Number
Place of Incorporation
Investors
DUNS Number
0869564680
IRS Number
61,549,4310
Total Funding Amount (USD)
58,000,000
Latest Funding Round Date
May 27, 2009
Latest Funding Type
CAGE Code
5H1S10
Wellfound ID
Other attributes
Company Operating Status
Closed
SIC Code
2,8340
Elixir Pharmaceuticals, no longer operating, was focused on the discovery, development, and commercialization of pharmaceuticals for treating metabolic diseases, such as diabetes and obesity.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.